On Thursday, the country recorded more than 20,000 cases of COVID-19, the highest number since the pandemic began. Oxygen is again running ...

Sinovac has finished the Phase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved t...

In a statement Tuesday, the U.N. health agency said data submitted to its experts showed that two doses of the vaccine prevented people fro...

The assessment came shortly after WHO SAGE experts had voiced "very low confidence" in data provided by Chinese state-owned drugmaker Sinop...

Sinovac and Sinopharm, the two Chinese manufacturers that combined have exported hundreds of millions of doses all over the world, say they...

There were two instances of high fevers in response to the vaccine during trials, one in a 3-year old participant and the other in a six-ye...

The emergence of variants of the new coronavirus has raised concern that vaccines and treatments that were developed based on previous stra...

Regulators gave conditional approval for Sinovac Biotech Ltd's shot, CoronaVac, on Friday, clearing the way for general use, The National M...

The vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use ...

The Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...

Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...

The country's health minister and members of the country's scientific advisory council received the first shots live on television, soon af...

The company is currently conducting the last stage of clinical trials for its vaccine candidate in Brazil, Turkey and Indonesia and is amon...

The health regulator, Anvisa, said on Monday the event took place on Oct. 29 but did not specify if the incident took place in Brazil or in...

In a letter to the Bangladesh government on September 22, Beijing headquartered Sinovac Biotech said the phase 3 trials of the vaccine they...

Sinovac Biotech Ltd in a letter on September 24 said the trial would be delayed unless the Bangladesh government provided funds, although t...

Sinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its ...